tradingkey.logo
tradingkey.logo
Search

Soligenix Inc - Positive Outcome In 75% Of Ctcl Patients Treated With Hybryte For 18 Weeks

ReutersApr 14, 2025 11:33 AM
facebooktwitterlinkedin

- Soligenix Inc SNGX.O:

  • SOLIGENIX INC - POSITIVE OUTCOME IN 75% OF CTCL PATIENTS TREATED WITH HYBRYTE FOR 18 WEEKS

  • SOLIGENIX INC - HYBRYTE APPEARS TO BE SAFE AND WELL TOLERATED IN ALL PATIENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI